Zifeng Pi

2.9k total citations
129 papers, 2.4k citations indexed

About

Zifeng Pi is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Zifeng Pi has authored 129 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 47 papers in Pharmacology and 29 papers in Complementary and alternative medicine. Recurrent topics in Zifeng Pi's work include Metabolomics and Mass Spectrometry Studies (36 papers), Ginseng Biological Effects and Applications (36 papers) and Pharmacological Effects of Natural Compounds (26 papers). Zifeng Pi is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (36 papers), Ginseng Biological Effects and Applications (36 papers) and Pharmacological Effects of Natural Compounds (26 papers). Zifeng Pi collaborates with scholars based in China, Canada and Macao. Zifeng Pi's co-authors include Zhiqiang Liu, Shu Liu, Fengrui Song, Fengrui Song, Xiaogang Qu, Jinsong Ren, Xiubo Du, Mengmeng Ma, Junpeng Xing and Nan Gao and has published in prestigious journals such as Journal of the American Chemical Society, ACS Nano and Biomaterials.

In The Last Decade

Zifeng Pi

123 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zifeng Pi China 27 1.3k 549 449 337 322 129 2.4k
Feng Feng China 36 2.1k 1.6× 590 1.1× 371 0.8× 196 0.6× 293 0.9× 221 4.8k
Hui Zhou China 25 757 0.6× 239 0.4× 128 0.3× 236 0.7× 248 0.8× 85 1.9k
Sheelendra Pratap Singh India 27 619 0.5× 218 0.4× 167 0.4× 224 0.7× 167 0.5× 90 2.2k
Zhenlong Yu China 32 1.3k 1.0× 408 0.7× 170 0.4× 193 0.6× 136 0.4× 99 2.7k
Xiangge Tian China 34 1.5k 1.2× 650 1.2× 160 0.4× 302 0.9× 124 0.4× 148 3.2k
Hong Yao China 31 1.1k 0.9× 246 0.4× 384 0.9× 87 0.3× 111 0.3× 146 3.0k
Cheng‐Peng Sun China 31 1.3k 1.1× 571 1.0× 324 0.7× 136 0.4× 90 0.3× 136 3.0k
Dong‐Mei Ren China 34 2.0k 1.5× 280 0.5× 357 0.8× 387 1.1× 131 0.4× 131 3.7k
Yanxu Chang China 30 1.6k 1.2× 682 1.2× 1.0k 2.3× 120 0.4× 109 0.3× 228 3.6k

Countries citing papers authored by Zifeng Pi

Since Specialization
Citations

This map shows the geographic impact of Zifeng Pi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifeng Pi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifeng Pi more than expected).

Fields of papers citing papers by Zifeng Pi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zifeng Pi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifeng Pi. The network helps show where Zifeng Pi may publish in the future.

Co-authorship network of co-authors of Zifeng Pi

This figure shows the co-authorship network connecting the top 25 collaborators of Zifeng Pi. A scholar is included among the top collaborators of Zifeng Pi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zifeng Pi. Zifeng Pi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shuhan, Tao Ren, Meiyu Zhang, et al.. (2024). Ginseng fermentation solution affects the gut microbiota in zebrafish with alcoholic liver disease via PI3K/Akt pathway. Phytomedicine. 128. 155495–155495. 5 indexed citations
3.
Men, Lihui, Zifeng Pi, Shu Liu, et al.. (2021). Serum Metabolomics Coupled with Network Pharmacology Strategy to Explore Therapeutic Effects of Scutellaria Baicalensis Georgi on Diabetic Nephropathy. Chinese Journal of Analytical Chemistry. 49(1). e21001–e21013. 1 indexed citations
4.
Ma, Mengmeng, Zhenqi Liu, Nan Gao, et al.. (2020). Self-Protecting Biomimetic Nanozyme for Selective and Synergistic Clearance of Peripheral Amyloid-β in an Alzheimer’s Disease Model. Journal of the American Chemical Society. 142(52). 21702–21711. 156 indexed citations
5.
Ma, Mengmeng, Nan Gao, Xuexia Li, et al.. (2020). A Biocompatible Second Near-Infrared Nanozyme for Spatiotemporal and Non-Invasive Attenuation of Amyloid Deposition through Scalp and Skull. ACS Nano. 14(8). 9894–9903. 117 indexed citations
6.
He, Yang, Yimin Wang, Shu Liu, et al.. (2020). A metabolomic study of the urine of rats with Alzheimer's disease and the efficacy of Ding‐Zhi‐Xiao‐Wan on the afflicted rats. Journal of Separation Science. 43(8). 1458–1465. 18 indexed citations
7.
Liu, Shuxin, Zifeng Pi, Zhiqiang Liu, Fengrui Song, & Shu Liu. (2020). Fecal metabolomics based on mass spectrometry to investigate the mechanism of qishen granules against isoproterenol‐induced chronic heart failure in rats. Journal of Separation Science. 43(23). 4305–4313. 11 indexed citations
8.
Wei, Mengying, Yuanyuan Liu, Zifeng Pi, et al.. (2019). Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35. RSC Advances. 9(32). 18308–18319. 5 indexed citations
10.
Wei, Mengying, Zhongying Liu, Yuanyuan Liu, et al.. (2019). Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS. Food & Function. 10(9). 5656–5668. 33 indexed citations
11.
Liu, Yuanyuan, Zhongying Liu, Mengying Wei, et al.. (2018). Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease. Food & Function. 10(1). 432–447. 54 indexed citations
12.
Liu, Yuanyuan, Mengying Wei, Shizhe Li, et al.. (2018). Study on Urine Metabolic Profile of Aβ25–35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS. Neuroscience. 394. 30–43. 28 indexed citations
13.
Han, Hongxiang, et al.. (2017). An Untargeted Urinary Metabolomics Strategy for Investigation of Therapeutical Mechanism of Schisandra chinensis on Complications of Diabetes Rats. CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION). 45(3). 389–396. 3 indexed citations
14.
Wang, Lu, Zifeng Pi, Shu Liu, Zhiqiang Liu, & Fengrui Song. (2016). [Application of modern mass spectrometry in metabolism and pharmacokinetics of traditional Chinese medicine].. PubMed. 51(8). 1217–26. 1 indexed citations
15.
Xu, Tengfei, Shu Liu, Guifang Feng, et al.. (2015). A study on the effective substance of the Wu-tou formula based on the metabonomic method using UPLC-Q-TOF-HDMS. Molecular BioSystems. 11(11). 3081–3091. 26 indexed citations
16.
Pi, Zifeng, et al.. (2015). Serumal Metabonomic Study on Mechanism of Schisandra Chinensis in Rat Diabetic Nephropathy. CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION). 169–175. 1 indexed citations
17.
Yao, Qi, Zifeng Pi, Shu Liu, et al.. (2014). A metabonomic study of adjuvant-induced arthritis in rats using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Molecular BioSystems. 10(10). 2617–2625. 27 indexed citations
18.
Liu, Yang, et al.. (2013). ABSORPTION OF HYPACONITINE AND P-GLYCOPROTEIN-MEDIATED DRUG-HYPACONITINE INTERACTIONS BY CACO-2 HUMAN INTESTINAL CELL MONOLAYERS. Journal of Liquid Chromatography & Related Technologies. 36(9). 1207–1220. 3 indexed citations
19.
Meng, Xiangyu, et al.. (2009). Analysis of the glycyrrhizic acid, liquiritin, ephedrine and methephedrine in the decoction of Ephedra-Glycyrrhiza preparated combination by HPLC-MS/MS & GC-MS. Chinese Journal of Applied Chemistry. 26(7). 801–806. 1 indexed citations
20.
Pi, Zifeng. (2009). Study on Plastics Transdermal Absorption of Berberine Hydrochloride of Complex Prescription Coptis chinensis. Lishizhen Medicine and Materia Medica Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026